Polyrizon (PLRZ) Competitors $0.70 -0.02 (-2.18%) As of 12:58 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock PLRZ vs. FLGC, BFRG, ACXP, ERNA, PRPH, EDSA, SYBX, UBX, CTXR, and GOVXShould you be buying Polyrizon stock or one of its competitors? The main competitors of Polyrizon include Flora Growth (FLGC), Bullfrog AI (BFRG), Acurx Pharmaceuticals (ACXP), Ernexa Therapeutics (ERNA), ProPhase Labs (PRPH), Edesa Biotech (EDSA), Synlogic (SYBX), UNITY Biotechnology (UBX), Citius Pharmaceuticals (CTXR), and GeoVax Labs (GOVX). These companies are all part of the "pharmaceutical products" industry. Polyrizon vs. Its Competitors Flora Growth Bullfrog AI Acurx Pharmaceuticals Ernexa Therapeutics ProPhase Labs Edesa Biotech Synlogic UNITY Biotechnology Citius Pharmaceuticals GeoVax Labs Polyrizon (NASDAQ:PLRZ) and Flora Growth (NASDAQ:FLGC) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability, media sentiment and earnings. Is PLRZ or FLGC more profitable? Polyrizon has a net margin of 0.00% compared to Flora Growth's net margin of -24.85%. Polyrizon's return on equity of 0.00% beat Flora Growth's return on equity.Company Net Margins Return on Equity Return on Assets PolyrizonN/A N/A N/A Flora Growth -24.85%-216.49%-45.56% Does the media prefer PLRZ or FLGC? In the previous week, Flora Growth had 4 more articles in the media than Polyrizon. MarketBeat recorded 4 mentions for Flora Growth and 0 mentions for Polyrizon. Flora Growth's average media sentiment score of 0.79 beat Polyrizon's score of 0.00 indicating that Flora Growth is being referred to more favorably in the news media. Company Overall Sentiment Polyrizon Neutral Flora Growth Positive Do analysts rate PLRZ or FLGC? Flora Growth has a consensus target price of $4.00, indicating a potential upside of 529.92%. Given Flora Growth's stronger consensus rating and higher probable upside, analysts clearly believe Flora Growth is more favorable than Polyrizon.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Polyrizon 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Flora Growth 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Do institutionals and insiders have more ownership in PLRZ or FLGC? 36.0% of Flora Growth shares are held by institutional investors. 12.6% of Flora Growth shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has higher valuation and earnings, PLRZ or FLGC? Polyrizon has higher earnings, but lower revenue than Flora Growth. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPolyrizonN/AN/A-$1.54MN/AN/AFlora Growth$59.51M0.24-$15.91M-$0.98-0.65 SummaryFlora Growth beats Polyrizon on 8 of the 12 factors compared between the two stocks. Get Polyrizon News Delivered to You Automatically Sign up to receive the latest news and ratings for PLRZ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PLRZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PLRZ vs. The Competition Export to ExcelMetricPolyrizonMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.84M$2.91B$5.54B$8.95BDividend YieldN/A2.42%5.38%4.08%P/E RatioN/A21.5627.4020.04Price / SalesN/A281.10419.46118.60Price / CashN/A41.9536.6357.47Price / Book0.007.518.085.67Net Income-$1.54M-$55.05M$3.16B$248.47M7 Day Performance-0.10%3.16%2.12%2.90%1 Month Performance-13.05%5.92%4.43%5.75%1 Year PerformanceN/A5.82%35.62%21.36% Polyrizon Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PLRZPolyrizonN/A$0.70-2.2%N/AN/A$3.84MN/A0.00N/APositive NewsGap DownFLGCFlora Growth3.0246 of 5 stars$0.66-0.8%$4.00+501.6%-40.5%$15.12M$59.51M-0.68280News CoverageBFRGBullfrog AI1.0398 of 5 stars$1.61+0.6%N/A-5.4%$15.06M$60K-1.994ACXPAcurx Pharmaceuticals2.6132 of 5 stars$0.57-9.9%$8.00+1,312.7%-77.5%$14.76MN/A-0.813News CoverageGap UpERNAErnexa Therapeutics0.6712 of 5 stars$1.88-5.1%N/A-92.6%$14.58M$580K-0.2310Negative NewsPRPHProPhase Labs1.4738 of 5 stars$0.35-0.3%N/A-89.4%$14.54M$5.85M-0.28130EDSAEdesa Biotech1.7596 of 5 stars$2.01+0.5%$21.00+944.8%-51.5%$14.05MN/A-1.2620Positive NewsSYBXSynlogic0.5352 of 5 stars$1.20+0.2%N/A-15.7%$13.95M$10K-0.4880Gap UpUBXUNITY Biotechnology4.2211 of 5 stars$0.79-1.5%$3.75+375.6%-77.3%$13.77M$240K-0.4960Gap DownCTXRCitius Pharmaceuticals2.1744 of 5 stars$1.20-7.0%$54.50+4,441.7%-83.6%$13.72MN/A0.0020Analyst ForecastHigh Trading VolumeGOVXGeoVax Labs3.3641 of 5 stars$0.90-0.6%$11.10+1,137.7%-85.6%$13.70M$3.95M-0.2510News Coverage Related Companies and Tools Related Companies Flora Growth Alternatives Bullfrog AI Alternatives Acurx Pharmaceuticals Alternatives Ernexa Therapeutics Alternatives ProPhase Labs Alternatives Edesa Biotech Alternatives Synlogic Alternatives UNITY Biotechnology Alternatives Citius Pharmaceuticals Alternatives GeoVax Labs Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PLRZ) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $100 Trillion AI Story No One Is Telling YouJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Polyrizon Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Polyrizon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PLRZ Stock Alerts